A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

Trial Profile

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2017

At a glance

  • Drugs BLI 400 (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Braintree Laboratories
  • Most Recent Events

    • 13 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 06 Apr 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 06 Apr 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top